{"entity":{"type":"insider","cik":"0001779805","url":"/insider/0001779805","json_url":"/insider/0001779805.json","name":"Young Jonathan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":57,"n_filings":42,"first":"2021-01-06","last":"2025-10-03","span_basis":"filed_date"},"name_variants":[{"name":"Young Jonathan","source":"filing","n_filings":42,"first_seen":"2021-01-06","last_seen":"2025-10-03"}],"transactions":[{"id":4795762,"accession":"0001193125-25-230294","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-230294","line_url":"/filing/0001193125-25-230294","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":47.7582672,"price_display":"47.76","price_state":"stated","total_value":596978.34,"total_display":"596,978.34","total_whole":"596,978","shares_owned_after":201099.0,"shares_owned_after_display":"201,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-03","scope":"insider","n_lines":2},{"id":4237244,"accession":"0000950170-25-114666","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-114666","line_url":"/filing/0000950170-25-114666#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":586.0,"shares_display":"586","price_per_share":43.02,"price_display":"43.02","price_state":"stated","total_value":25209.72,"total_display":"25,209.72","total_whole":"25,210","shares_owned_after":196898.0,"shares_owned_after_display":"196,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-11","filed_date":"2025-09-12","scope":"insider"},{"id":4897141,"accession":"0001779805-25-000007","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001779805-25-000007","line_url":"/filing/0001779805-25-000007","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":46.08280672,"price_display":"46.08","price_state":"stated","total_value":576035.084,"total_display":"576,035.08","total_whole":"576,035","shares_owned_after":200284.0,"shares_owned_after_display":"200,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-04","scope":"insider","n_lines":3},{"id":4983678,"accession":"0000950170-25-108234","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-108234","line_url":"/filing/0000950170-25-108234","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":47.78607576,"price_display":"47.79","price_state":"stated","total_value":597325.947,"total_display":"597,325.95","total_whole":"597,326","shares_owned_after":198833.0,"shares_owned_after_display":"198,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-13","scope":"insider","n_lines":2},{"id":4027814,"accession":"0000950170-25-088635","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-088635","line_url":"/filing/0000950170-25-088635#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1453.0,"shares_display":"1,453","price_per_share":54.84,"price_display":"54.84","price_state":"stated","total_value":79682.52,"total_display":"79,682.52","total_whole":"79,683","shares_owned_after":196594.0,"shares_owned_after_display":"196,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-18","filed_date":"2025-06-20","scope":"insider"},{"id":4462455,"accession":"0000950170-25-085667","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-085667","line_url":"/filing/0000950170-25-085667#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2493.0,"shares_display":"2,493","price_per_share":53.993,"price_display":"53.99","price_state":"stated","total_value":134604.549,"total_display":"134,604.55","total_whole":"134,605","shares_owned_after":198047.0,"shares_owned_after_display":"198,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-10","filed_date":"2025-06-12","scope":"insider"},{"id":4340809,"accession":"0000950170-25-039745","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-039745","line_url":"/filing/0000950170-25-039745#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":607.0,"shares_display":"607","price_per_share":44.88,"price_display":"44.88","price_state":"stated","total_value":27242.16,"total_display":"27,242.16","total_whole":"27,242","shares_owned_after":200540.0,"shares_owned_after_display":"200,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-14","scope":"insider"},{"id":4495150,"accession":"0000950170-25-033998","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-033998","line_url":"/filing/0000950170-25-033998","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":44.86426718,"price_display":"44.86","price_state":"stated","total_value":2243213.359,"total_display":"2,243,213.36","total_whole":"2,243,213","shares_owned_after":201147.0,"shares_owned_after_display":"201,147","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-05","scope":"insider","n_lines":2},{"id":4233943,"accession":"0000950170-25-014188","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-014188","line_url":"/filing/0000950170-25-014188","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":53.80608,"price_display":"53.81","price_state":"stated","total_value":538060.8,"total_display":"538,060.80","total_whole":"538,061","shares_owned_after":256047.0,"shares_owned_after_display":"256,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-05","scope":"insider","n_lines":2},{"id":4454625,"accession":"0000950170-25-001850","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-001850","line_url":"/filing/0000950170-25-001850#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":28.033,"price_display":"28.03","price_state":"stated","total_value":280330.0,"total_display":"280,330.00","total_whole":"280,330","shares_owned_after":218083.0,"shares_owned_after_display":"218,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-06","scope":"insider"},{"id":3036398,"accession":"0000950170-24-136023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-136023","line_url":"/filing/0000950170-24-136023#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2503.0,"shares_display":"2,503","price_per_share":30.79,"price_display":"30.79","price_state":"stated","total_value":77067.37,"total_display":"77,067.37","total_whole":"77,067","shares_owned_after":203783.0,"shares_owned_after_display":"203,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-10","filed_date":"2024-12-12","scope":"insider"},{"id":2903430,"accession":"0000950170-24-133434","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-133434","line_url":"/filing/0000950170-24-133434#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":32.131,"price_display":"32.13","price_state":"stated","total_value":321310.0,"total_display":"321,310.00","total_whole":"321,310","shares_owned_after":206286.0,"shares_owned_after_display":"206,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-04","scope":"insider"},{"id":2073323,"accession":"0000950170-24-121102","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-121102","line_url":"/filing/0000950170-24-121102","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50716.0,"shares_display":"50,716","price_per_share":31.57290703131162,"price_display":"31.57","price_state":"stated","total_value":1601251.553,"total_display":"1,601,251.55","total_whole":"1,601,252","shares_owned_after":232059.0,"shares_owned_after_display":"232,059","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-01","filed_date":"2024-11-05","scope":"insider","n_lines":3},{"id":2073201,"accession":"0000950170-24-115139","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-115139","line_url":"/filing/0000950170-24-115139#line-2","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":30.152,"price_display":"30.15","price_state":"stated","total_value":1206080.0,"total_display":"1,206,080.00","total_whole":"1,206,080","shares_owned_after":226286.0,"shares_owned_after_display":"226,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-14","filed_date":"2024-10-16","scope":"insider"},{"id":2951862,"accession":"0000950170-24-112672","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-112672","line_url":"/filing/0000950170-24-112672#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":28.177,"price_display":"28.18","price_state":"stated","total_value":281770.0,"total_display":"281,770.00","total_whole":"281,770","shares_owned_after":226286.0,"shares_owned_after_display":"226,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-03","scope":"insider"},{"id":2389373,"accession":"0000950170-24-106473","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-106473","line_url":"/filing/0000950170-24-106473#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":568.0,"shares_display":"568","price_per_share":26.18,"price_display":"26.18","price_state":"stated","total_value":14870.24,"total_display":"14,870.24","total_whole":"14,870","shares_owned_after":236286.0,"shares_owned_after_display":"236,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-13","scope":"insider"},{"id":2206261,"accession":"0000950170-24-103986","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-103986","line_url":"/filing/0000950170-24-103986","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":26.717506,"price_display":"26.72","price_state":"stated","total_value":133587.53,"total_display":"133,587.53","total_whole":"133,588","shares_owned_after":238144.0,"shares_owned_after_display":"238,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-03","filed_date":"2024-09-05","scope":"insider","n_lines":2},{"id":2771683,"accession":"0000950170-24-090257","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-090257","line_url":"/filing/0000950170-24-090257","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":26.751102,"price_display":"26.75","price_state":"stated","total_value":133755.51,"total_display":"133,755.51","total_whole":"133,756","shares_owned_after":243823.0,"shares_owned_after_display":"243,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-01","filed_date":"2024-08-02","scope":"insider","n_lines":2},{"id":2678587,"accession":"0000950170-24-080921","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-080921","line_url":"/filing/0000950170-24-080921#line-2","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":23.404,"price_display":"23.40","price_state":"stated","total_value":117020.0,"total_display":"117,020.00","total_whole":"117,020","shares_owned_after":246854.0,"shares_owned_after_display":"246,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-02","scope":"insider"},{"id":3254916,"accession":"0000950170-24-073192","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-073192","line_url":"/filing/0000950170-24-073192#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2516.0,"shares_display":"2,516","price_per_share":22.641,"price_display":"22.64","price_state":"stated","total_value":56964.756,"total_display":"56,964.76","total_whole":"56,965","shares_owned_after":250790.0,"shares_owned_after_display":"250,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-11","filed_date":"2024-06-13","scope":"insider"},{"id":3152261,"accession":"0000950170-24-069416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-069416","line_url":"/filing/0000950170-24-069416#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":19.288,"price_display":"19.29","price_state":"stated","total_value":96440.0,"total_display":"96,440.00","total_whole":"96,440","shares_owned_after":253306.0,"shares_owned_after_display":"253,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider"},{"id":2342847,"accession":"0000950170-24-052445","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-052445","line_url":"/filing/0000950170-24-052445#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.1499,"price_display":"20.15","price_state":"stated","total_value":100749.5,"total_display":"100,749.50","total_whole":"100,750","shares_owned_after":258306.0,"shares_owned_after_display":"258,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-01","filed_date":"2024-05-02","scope":"insider"},{"id":3020101,"accession":"0000950170-24-041407","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-041407","line_url":"/filing/0000950170-24-041407","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stoek","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":24.382564,"price_display":"24.38","price_state":"stated","total_value":121912.82,"total_display":"121,912.82","total_whole":"121,913","shares_owned_after":263306.0,"shares_owned_after_display":"263,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider","n_lines":2},{"id":2768291,"accession":"0000950170-24-032262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-032262","line_url":"/filing/0000950170-24-032262#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":651.0,"shares_display":"651","price_per_share":28.33,"price_display":"28.33","price_state":"stated","total_value":18442.83,"total_display":"18,442.83","total_whole":"18,443","shares_owned_after":268306.0,"shares_owned_after_display":"268,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-13","filed_date":"2024-03-15","scope":"insider"},{"id":8528634,"accession":"0000899243-23-020714","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-020714","line_url":"/filing/0000899243-23-020714#line-2","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5414.0,"shares_display":"5,414","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":129936.0,"total_display":"129,936.00","total_whole":"129,936","shares_owned_after":185131.0,"shares_owned_after_display":"185,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-27","filed_date":"2023-12-29","scope":"insider"},{"id":7995664,"accession":"0000950170-23-071245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-071245","line_url":"/filing/0000950170-23-071245#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":543.0,"shares_display":"543","price_per_share":20.76,"price_display":"20.76","price_state":"stated","total_value":11272.68,"total_display":"11,272.68","total_whole":"11,273","shares_owned_after":185131.0,"shares_owned_after_display":"185,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-18","scope":"insider"},{"id":8599772,"accession":"0000950170-23-065611","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-065611","line_url":"/filing/0000950170-23-065611#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":14.6753,"price_display":"14.68","price_state":"stated","total_value":440259.0,"total_display":"440,259.00","total_whole":"440,259","shares_owned_after":153177.0,"shares_owned_after_display":"153,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-17","filed_date":"2023-11-21","scope":"insider"},{"id":8310853,"accession":"0000950170-23-052052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-052052","line_url":"/filing/0000950170-23-052052#line-2","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":490.0,"shares_display":"490","price_per_share":51.1,"price_display":"51.10","price_state":"stated","total_value":25039.0,"total_display":"25,039.00","total_whole":"25,039","shares_owned_after":183177.0,"shares_owned_after_display":"183,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-02","filed_date":"2023-10-04","scope":"insider"},{"id":8518547,"accession":"0000950170-23-049762","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-049762","line_url":"/filing/0000950170-23-049762#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":562.0,"shares_display":"562","price_per_share":50.34,"price_display":"50.34","price_state":"stated","total_value":28291.08,"total_display":"28,291.08","total_whole":"28,291","shares_owned_after":183177.0,"shares_owned_after_display":"183,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-13","filed_date":"2023-09-25","scope":"insider"},{"id":8062970,"accession":"0000899243-23-015669","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-015669","line_url":"/filing/0000899243-23-015669#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":538.0,"shares_display":"538","price_per_share":55.16,"price_display":"55.16","price_state":"stated","total_value":29676.08,"total_display":"29,676.08","total_whole":"29,676","shares_owned_after":183739.0,"shares_owned_after_display":"183,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-15","scope":"insider"},{"id":8244057,"accession":"0000899243-23-001028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-001028","line_url":"/filing/0000899243-23-001028#line-2","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8777.0,"shares_display":"8,777","price_per_share":54.6383,"price_display":"54.64","price_state":"stated","total_value":479560.3591,"total_display":"479,560.36","total_whole":"479,560","shares_owned_after":184911.0,"shares_owned_after_display":"184,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":6742284,"accession":"0000899243-22-039460","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-039460","line_url":"/filing/0000899243-22-039460#line-3","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":49.5687,"price_display":"49.57","price_state":"stated","total_value":619608.75,"total_display":"619,608.75","total_whole":"619,609","shares_owned_after":182449.0,"shares_owned_after_display":"182,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-27","filed_date":"2022-12-28","scope":"insider"},{"id":6319118,"accession":"0000899243-22-034371","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-034371","line_url":"/filing/0000899243-22-034371#line-2","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":44.7155,"price_display":"44.72","price_state":"stated","total_value":558943.75,"total_display":"558,943.75","total_whole":"558,944","shares_owned_after":163254.0,"shares_owned_after_display":"163,254","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-10-27","scope":"insider"},{"id":4366237,"accession":"0001104659-21-135039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-135039","line_url":"/filing/0001104659-21-135039#line-2","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6220.0,"shares_display":"6,220","price_per_share":24.33,"price_display":"24.33","price_state":"stated","total_value":151332.6,"total_display":"151,332.60","total_whole":"151,333","shares_owned_after":135510.0,"shares_owned_after_display":"135,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-04","filed_date":"2021-11-05","scope":"insider"},{"id":4366233,"accession":"0001104659-21-135039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-135039","line_url":"/filing/0001104659-21-135039#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18780.0,"shares_display":"18,780","price_per_share":24.27,"price_display":"24.27","price_state":"stated","total_value":455790.6,"total_display":"455,790.60","total_whole":"455,791","shares_owned_after":141730.0,"shares_owned_after_display":"141,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-03","filed_date":"2021-11-05","scope":"insider"},{"id":4876952,"accession":"0001104659-21-112970","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-112970","line_url":"/filing/0001104659-21-112970#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":24.04,"price_display":"24.04","price_state":"stated","total_value":300500.0,"total_display":"300,500.00","total_whole":"300,500","shares_owned_after":160510.0,"shares_owned_after_display":"160,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-03","scope":"insider"},{"id":4768132,"accession":"0001104659-21-075727","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-075727","line_url":"/filing/0001104659-21-075727#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3055.0,"shares_display":"3,055","price_per_share":26.236,"price_display":"26.24","price_state":"stated","total_value":80150.98,"total_display":"80,150.98","total_whole":"80,151","shares_owned_after":164010.0,"shares_owned_after_display":"164,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-02","scope":"insider"},{"id":4457918,"accession":"0001104659-21-060961","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-060961","line_url":"/filing/0001104659-21-060961#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3055.0,"shares_display":"3,055","price_per_share":30.56,"price_display":"30.56","price_state":"stated","total_value":93360.8,"total_display":"93,360.80","total_whole":"93,361","shares_owned_after":167065.0,"shares_owned_after_display":"167,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-04","scope":"insider"},{"id":5501850,"accession":"0001104659-21-046655","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-046655","line_url":"/filing/0001104659-21-046655#line-1","is_derivative":false,"issuer_cik":"0001744659","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001744659","owner_cik":"0001779805","owner_name":"Young Jonathan","owner_display_name":"Young Jonathan","owner_url":"/insider/0001779805","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3055.0,"shares_display":"3,055","price_per_share":28.7488,"price_display":"28.75","price_state":"stated","total_value":87827.584,"total_display":"87,827.58","total_whole":"87,828","shares_owned_after":170120.0,"shares_owned_after_display":"170,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-05","scope":"insider"}],"collapsed":true,"next_cursor":"2021-04-01|5501850","ledger_fault":false,"count":{"value":57,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":57,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":57},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001744659","name":"Akero Therapeutics, Inc.","url":"/issuer/0001744659","role":"Officer (Chief Operating Officer)","n_filings":42,"first_seen":"2021-01-06","last_seen":"2025-10-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001779805","retrieved_at":"2026-08-23T12:37:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}